The therapeutic use of androgens in women

Journal of Steroid Biochemistry and Molecular Biology

Volumn 69, Issue 1-6, 1999, Pages 177-184

  Davis, S R ^a  

^a Jean Hailes Foundation for Women's Health   (Australia)

Author keywords

Androgens in women; Hormone replacement therapy; Testosterone and menopause

Indexed keywords

ANDROGEN; ANDROSTANOLONE; ANDROSTENEDIONE; ANTICOAGULANT AGENT; APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLTESTOSTERONE; NANDROLONE DECANOATE; NITRIC OXIDE; OXYPHENBUTAZONE; PRASTERONE; PRASTERONE SULFATE; SEX HORMONE; TESTOSTERONE;

BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; CONFERENCE PAPER; DRUG CONTRAINDICATION; FEMALE; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MENOPAUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; QUALITY OF LIFE; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSDERMAL DRUG ADMINISTRATION; VIRILIZATION; WELLBEING;

AGING; ANDROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; POSTMENOPAUSE; TESTOSTERONE;

EID: 0033015913     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(99)00054-0     Document Type: Conference Paper

References (66)

1. Zumoff B., Strain G.W., Miller L.K., Rosner W. Twenty-four hour mean plasma testosterone concentration declines with age in normal premenopausal women. J. Clin. Endocrinol. Metab. 80:1995;1429-1430.
2. Zumoff B., Rosenfeld R.S., Strain G.W. Sex differences in the 24 hour mean plasma concentrations of dehydroisoandrosterone (DHA) and dehydroisoandrosterone sulfate (DHAS) and the DRA to DHAS ratio in normal adults. J. Clin. Endocrinol. Metab. 51:1980;330-334.
3. Sands R., Studd J. Exogenous androgens in postmenopausal women. Am. J. Med. 98:1995;765-795.
4. Frock J., Money J. Sexuality and the menopause. Psychother. Psychosom. 57:1992;29-33.
5. Steinberg K.K., Freni-titulaer L.W., De Puey E.G. Sex steroids and bone density in premenopausal and permenopausal women. J. Clin. Endocrinol. Metab. 69:1989;533-539.
6. Hallstrom T. Sexuality in the climacteric. J. Clin. Obstet. Gynecol. 4:1977;227-239.
7. Haning R.V. Jr, Cabot M., Flood C.A., Hackett R., Longcope C. Metabolic clearance rate (MCR) of dehydroepiandrosterone sulfats (DS) its metabolism to dehydroepiandrosterone, androstenedione testosterone and dihydrotestosterone, and the effects of increased plasm DS concentration on DS MCR in normal women. J. Clin. Endocrinol. Metab. 69:1989;1047-1052.
8. Judd H.L., Yen S.S.C. Serum androstenedione and testosterone levels during the menstrual cycle. J. Clin. Endocrinol. Metab. 36:1973;475-481.
9. Rannevik G., Jeppsson S., Johnell O. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones. SHBG and bone mineral density. Maturitas. 8:1986;189-196.
10. Dunn J.F., Nisula B.C. Transport of steroid hormones. Binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in plasma. J. Clin. Endocrinol. Metab. 53:1981;58-68.
11. Meldrum D.R. Changes in circulating steroids with aging in post menopausal women. Obstet. Gynecol. 57:1997;624-628.
12. Mushayandebvu T., Castracane D.V., Gimpel T., Adel T., Santoro N. Evidence for diminished midcycle ovarian androgen production in older reproductive aged women. ]Fertil. Steril. 65:1991;721-723.
13. Longcope C., Franz C., Morello C., Baker Y., Johnston C.C. Jr. Steroid and gonadotropin levels in women during the peri-menopausal years. Maturitas. 8:1986;1189-1196.
14. Judd H.L., Lucas W.E., Yen S.S.C. Effect of oopherectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am. J. Obstet. Gynecol. 118:(6):1994;793-798.
15. Procope B. Studies on the urinary excretion, biological effects and origina of estrogens in postmenopausal women. Acta Endocrinol. (Copenh.). 135:1968;1-86.
16. Judd H.L. Hormonal dynamics associated with the menopause. Clin. Obstet. Gynecol. 19:1976;775-788.
17. Krug R., Psych D., Pietrowsky R., Fehm H.L., Born J. Selective influence of menstrual cycle on perception of stimuli with reproductive significance. Psychosom. Med. 56:1994;410-417.
18. Mathur R.S., Landgreve S.C., Moody L.O., Semmens J.P., Williamson H.O. The effect of estrogen treatment on plasma concentrations of steroid hormones, gonadotropins, prolactin and sex hormone-binding globulin in post-menopausal women. Maturitas. 7:1985;129-133.
19. Tazuke S., Khaw K-T., Chir M.M.B., Barrett-Connor E. Exogenous estrogen and endogenous sex hormones. Medicine. 71:1992;44-51.
20. Bancroft J., Cawood E.H.H. Androgens and the menopause: a study of 40-60 year old women. Clin. Endocrinol. 45:1996;577-587.
21. Abraham G.E. Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. J. Clin. Endocrinol. Metab. 39:1974;340-346.
22. Pearce G., Tabensky D.A., Delmas P.D., Baker H.W.G., Seeman E. Corticosteroid-Induced Bone Loss in Men. J. Clin. Endocrinol. Metab. 83:(3):1998;801-806.
23. Davis S.R., McCloud P.I., Strauss B.J.G., Burger H. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas. 21:1995;227-236.
24. Watts N.B., Notelovitz M., Timmons M.C. Comparison of oral estrogens and estrogens plus androgen in bone mineral density, menopausal symptoms and lipid-lipoprotein profiles in surgical menopause. Obstet. Gynecol. 85:1995;529-537.
25. Dennerstein L., Smith A., Morse C., Burger H. Sexuality and the menopause. J. Psychsom. Obstet. Gynecol. 15:1994;56-59.
26. McCoy N.L., Davidson J.M-I. A longitudinal study of the effect of menopause on sexuality. Maturitas. 7:1985;203-210.
27. Campbell S., Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin. Obstet. Gynecol. 4:1977;31-47.
28. Utian W.H. The true clinical features of postmenopausal oophorectomy and their response to estrogen replacement in therapy. S. Afr. Med, J. 46:1972;732-737.
29. Studd J.W.W., Colins W.P., Chakravarti S. Estradiol and testosterone implants in the treatment of psychosexual problems in postmenopausal women. Br. J. Obstet. Gynaecol. 84:1977;314-315.
30. Sherwin B.N., Gelfand M.M., Brender W. Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in surgical menopause. Psychosom. Med. 47:1997;339-351.
31. Bachmann G.A., Leiblum S.R. Sexuality in sexagenarian women. Maturitas. 13:1991;45-50.
32. Sherwin B.N., Gelfand M.M. The role of androgen in the maintenance of sexual function in oophorectomized women. Psychosom. Med. 49:1987;397-409.
33. Bixo K., Backstrom T., Winblad B., Andersson A. Estradiol and testosterone in specific regions of the human female brain in different endocrine states. J. Steroid Biochem. Mol. Biol. 55:1995;297-303.
34. Roselli C.E., Resko J.A. Aromatase activity in the rat brain: hormone regulation and sex differences. J. Steroid Biochem. Mol. Biol. 44:1993;499-508.
35. Van Goozen S.H.M., Cohen-Kettensis P.T., Gooren L.I.G., Frijda N.H., Van de Poll N.E. Gender differences in behaviour; activating effects of cross-sex hormones. Psychoneuroendocrinology. 20:1995;343-363.
36. Burger H.G., Hailes J., Menelaus M. The management of persistent symptoms with estradiol-testosterone implants clinical, lipid and hormonal results. Maturitas. 6:1984;351-358.
37. Burger H.G., Hailes J., Nelson J., Menelaus M. Effect of combined implants of estradiol and testosterone on libido in postmenopausal women. Br. Med. J. 294:1987;936-1937.
38. Smith E.P., Boyd J., Frank G.R., et al. Estrogen resistance caused by a mutation in the oestrogen-receptor gene in a man. N. Eng. J. Med. 331:1994;1056-1061.
39. Morales A.J., Nolan J.J., Nelson J.C., Yen S.S.C. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. Endocrinol. Metab. 78:1994;1360-1367.
40. Colvard D.S., Eriksen E.F., Keeling P.E. Identification of androgen receptors in normal human osteoblast-like cells. Proc. Natl. Acad. Sci. USA. 86:1989;854-857.
41. Kasperk C.H., Faeling K., Borcsok I., Zieggler R. Effects of androgen on sub-populations of the human osteosarcoma cell-line SA0S2. Calcif. Tissue Int. 58:1996;376-382.
42. Nilas L., Christiansen C. Bone mass and its relationship to age and the menopause. J. Clin. Endocrinol. Metab. 65:1987;697-699.
43. Siemenda C., Longcope C., Peacock M., Hui S., Johnston C.C. Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri- and postmenopausal women. J. Clin. Invest. 97:1996;14-21.
44. Jassal S.K., Barrett-Connor E., Edelstein S. Low bioavailable testosterone levels predict future height loss in postmenopausal women. J. Bone Min. Res. 10:(4):1995;650-653.
45. Nawata H., Tariaka S. Aromatase in bone cell: association with osteoporosis in post menopausal women. J. Steroid Biochem. Molec. Biol. 53:1995;165-174.
46. Nordin B.E.C., Robertson A., Seamark R.F., Bridges A., Philcox J.C., Need A.G., Horrowitz M., Morris H.A., Dearn S. The relation between calcium absorption serum DHEA and vertebral mineral density in postmenopausal women. J. Clin. Endocrinol. Metab. 60:1985;651-657.
47. Stampfer J.J., Golitz G.F.A., Willett W.C. Postmenopausal estrogen therapy and cardiovascular disease: Ten year follow up from the Nurses' Health Study. N. Eng. J. Med. 325:1991;756-762.
48. Savvas M., Studd J.W.W., Norman S., Leather A.T., Garnett T.J. Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in post menopausal women who have previously received long-term oral oestrogens. Br. J. Obstet. Gynaecol. 99:1992;757-760.
49. Raisz L.G., Wiita B., Artis A., Bowen A., Schwartz S., Trahiotis M., Shoukri K., Smith J. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J. Clin. Endocrinol. Metab. 81:1995;37-43.
50. Need G.A., Horowitz M., Bridges A., Morris H., Nordin C. Effects of nandrolone decanoate and antiresorptive therapy on vertebral density in osteoporotic women. Arch. Intern. Med. 149:1989;57-60.
51. Raudaskoski T.H., Tomas E.I., Paakkri I.A., Kauppila A.J., Laatikainen T.J. Serum lipids and lipoproteins in postmenopausal women receiving transdermal oestrogen in combination with leronorgestral-releasing inter uterine device. Maturitas. 22:1995;47-53.
52. Kasra M., Grynpas M.D. The effects of androgens on the mechanical properties of primate bone. Bone. 17:1995;265-270.
53. Masi A.T., Feigenbaum S.L., Chatterton R.T. Hormonal and pregnancy relationships to rheumatoid arthritis: Convergent effects with immunological and microvascular systems. Semin. Arthritis. Rheum. 25:1995;1-27.
54. Cutolo M., Seriolo B., Sulli A., Accardo S. Androgens in rheumatoid arthritis. Bijlsma J.W.J., Linden S., van der Barnes C.G. Rheumatology highlights 1995. Rheumatol. Eur. 24:1995;211-214.
55. Wilder R.L. Adrenal and gonadal steroid hormone deficiency m the pathogenesis of rheumatoid arthritis. J. Rheumatol. Suppl. 44:1996;10-12.
56. Sullivan D.A., Edwards J.A. Androgen stimulation of lacrinal gland function in mouse models of Sjogren's syndrome. J. Steroid Biochem. Mol. Biol. 60:(34):1997;237-245.
57. Goodman-Gruen D., Barrett-Connor E. Total but not bioavailable testosterone is a predictor of central adiposity in postmenopausal women. Int. J. Obes. 19:1995;293-298.
58. Hickok L.R., Toomey C., Speroff L. A comparison of esterified estrogens with and without methyltestosterone: Effects on endometrial histology andserum lipoproteins in postmenopausal women. Obstet. Gynecol. 82:1993;919-924.
59. Barrett-Connor E., Goodman-Gruen D. Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women. B.M.J. 311:1995;1193-1196.
60. Barrett-Connor E., Goodman-Gruen D. Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women. The Rancho Bernardo Study. Circulation. 91:1995;1757-1760.
61. Chou T.K., Sudhir K., Hutchison S.J., Ko E., Amidon T.M., Collins P., Chatterjee K. Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation. 94:1996;2614-2619.
62. Secreto G., Toniolo P., Pisani P., Recchione C., Cavalleri A., Farisella G., Totis A., Di Petro S. Androgens and breast cancer in menopausal women. Cancer Res. 49:1989;471-1476.
63. Secreto G., Toniolo P., Berrino E., Recchione C., Cavalleri A., Pisani P., Totis A., Farisella G., Di Petro S. Serum and urinary androgens and risk of breast cancer in postmenopausal women. Cancer Res. 51:1991;2572-2576.
64. Recchione C., Venturelli E., Manzari A., Cavalteri A., Martinetti A., Secreto G. Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissues. J. Steroid Biochem. Mol. Biol. 52:1995;541-546.
65. Bryan R.M., Mercer R.J., Renni G.C., Lie T.H., Morgan F.J. Androgen receptors in breast cancer. Cancer. 54:1984;2436-2440.
66. Buckler M., Evans C.A., Mamtora H., Burger H., Anderson D.C. Gonadotrophin steroid and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory, menstrual cycles. J. Clin. Endocrinol. Metab. 72:1991;116-124.